Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AYLA

Ayala Pharmaceuticals (AYLA) Stock Price, News & Analysis

Ayala Pharmaceuticals logo

About Ayala Pharmaceuticals Stock (NASDAQ:AYLA)

Advanced Chart

Key Stats

Today's Range
$0.50
$0.50
50-Day Range
$0.38
$0.58
52-Week Range
$0.36
$7.31
Volume
N/A
Average Volume
76,300 shs
Market Capitalization
$7.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AYLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AYLA Stock News Headlines

OS Therapies to acquire listeria programs from Ayala Pharmaceuticals
OS Therapies Expands Pipeline With Ayala Asset Acquisition, Stock Up
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
ADXS Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals (ADXS) Earnings Dates & Reports
Advaxis, Inc.: Advaxis and Ayala Pharmaceuticals Complete Merger
See More Headlines

AYLA Stock Analysis - Frequently Asked Questions

Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) issued its quarterly earnings results on Monday, November, 15th. The company reported ($0.68) EPS for the quarter, topping the consensus estimate of ($0.80) by $0.12. The firm had revenue of $0.63 million for the quarter, compared to analysts' expectations of $0.82 million. Ayala Pharmaceuticals had a negative net margin of 2,341.69% and a negative trailing twelve-month return on equity of 182.13%.

Ayala Pharmaceuticals (AYLA) raised $50 million in an initial public offering on Friday, May 8th 2020. The company issued 3,300,000 shares at $14.00-$16.50 per share. Citigroup and Jefferies served as the underwriters for the IPO and Oppenheimer and Raymond James were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ayala Pharmaceuticals investors own include HubSpot (HUBS), Netflix (NFLX), ForgeRock (FORG), Bank of America (BAC), ConocoPhillips (COP) and Diamondback Energy (FANG).

Company Calendar

Last Earnings
11/15/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AYLA
CIK
1797336
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.25 million
Net Margins
-2,341.69%
Pretax Margin
-2,298.60%
Return on Equity
-182.13%
Return on Assets
-139.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.28
Quick Ratio
2.28

Sales & Book Value

Annual Sales
$3.51 million
Price / Sales
2.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
14,821,000
Free Float
14,287,000
Market Cap
$7.46 million
Optionable
Not Optionable
Beta
1.98
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AYLA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners